Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

494
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
494
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

682
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
682
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

579
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
579
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

531
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
531
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

449
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
449
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

359
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Penile Rehabilitation After Surgery for Prostate Cancer: An Umbrella Review on Traditional Approaches and Novel Perspectives.

Journal of clinical medicine·2026
Same author

Genetic dissection of root traits in barley identifies major QTLs and domestication signature.

Plant cell reports·2026
Same author

TAVR in Low-Risk Patients at Long-Term Follow-Up: Promising Outcomes With Remaining Uncertainties from an Updated Meta-Analysis.

The American journal of cardiology·2026
Same author

Penile prosthesis implantation for patients with comorbid severe premature ejaculation and erectile dysfunction: a pilot cohort study.

International journal of impotence research·2026
Same author

A rare case of penile granulomatosis with polyangiitis: case report and multidisciplinary management approach.

Frontiers in urology·2026
Same author

Immediate versus staged complete revascularization using drug-eluting stents in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: An updated meta-analysis after the OPTION-STEMI trial.

Kardiologia polska·2026
Same journal

Giornale italiano di cardiologia (2006)·2026
Same journal

[Green paper ANMCO: Environmental sustainability in cardiology: a shared commitment of healthcare professionals].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Ranolazine: established indications and emerging therapeutic potential].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Kawasaki disease: the update of American Heart Association guidelines. What adult cardiologists need to know].

Giornale italiano di cardiologia (2006)·2026
Same journal

[The application of artificial intelligence in arrhythmology].

Giornale italiano di cardiologia (2006)·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K

[Percutaneous intervention therapy for vascular erectile dysfunction].

Giuseppe Sangiorgi1, Riccardo Colantonio2, Gabriele Antonini3

  • 1Università degli Studi "Tor Vergata", Roma.

Giornale Italiano Di Cardiologia (2006)
|October 13, 2016
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction (ED), often linked to cardiovascular issues, can be treated with endovascular interventions. These procedures show promise for improving symptoms and quality of life in patients with vascular ED.

More Related Videos

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.8K
Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

1.4K

Related Experiment Videos

Last Updated: Mar 13, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.8K
Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

1.4K

Area of Science:

  • Cardiology
  • Urology
  • Vascular Medicine

Background:

  • Erectile dysfunction (ED) significantly impacts quality of life, causing psychological distress and relational issues.
  • Atherosclerosis of penile arteries is a frequent cause of ED, particularly in patients with cardiovascular disease risk factors.
  • Iliac-pudendus-penile artery stenosis affects up to 75% of ED patients, highlighting the vascular component.

Purpose of the Study:

  • To review the anatomy and physiology of erection.
  • To discuss the pathophysiology of ED, emphasizing its link to cardiovascular health.
  • To explore endovascular interventions as a treatment for vascular ED.

Main Methods:

  • Review of literature on erection physiology and ED pathophysiology.
  • Analysis of the relationship between ED and ischemic cardiomyopathy.
  • Examination of endovascular treatment options for vascular ED.

Main Results:

  • Vascular ED shares common pathophysiology with cardiovascular diseases.
  • Percutaneous endovascular interventions offer promising angiographic and symptomatic outcomes.
  • Significant improvements in quality of life are reported post-intervention.

Conclusions:

  • Cardiologists should screen for vascular ED in at-risk patients.
  • Endovascular treatment is a viable option for managing vascular ED.
  • Addressing vascular causes of ED can improve patient outcomes and well-being.